For decades, British workplaces have measured employee wellbeing in days off. A bout of flu, a chest infection, a sprained ankle: a few sick notes, a fit-to-return form, and the matter is closed.
Yet a growing body of clinical evidence, and a steady drumbeat of employment tribunal cases, suggests that this tidy framework is wholly unfit to deal with the reproductive health challenges that thousands of British workers quietly navigate every day.
Fertility treatment, pregnancy loss and the menopause are, in the words of one consultant, fundamentally different beasts. They cannot be cleared by a course of antibiotics. They are not, in any meaningful sense, temporary. And, crucially for employers, the cost of getting the response wrong is no longer simply a matter of compassion, it is a matter of retention, productivity and, increasingly, legal exposure.
The conventional model of workplace illness assumes a hurdle that the body eventually clears. IVF, miscarriage and menopause do not behave that way. They are tied to identity, to the future a person had imagined for themselves, and to a biological transition that can play out over months or years rather than days.
A miscarriage is, in effect, a bereavement requiring emotional processing alongside physical recovery. IVF involves systemic hormonal shifts that are unpredictable in both timing and intensity. The menopause, increasingly recognised as a workplace issue in its own right, brings vasomotor and cognitive symptoms that can persist for the better part of a decade. None of these is a short-term medical issue, and treating them as such is the first mistake too many British employers continue to make.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
